Circulating levels of liver enzymes and incidence of atrial fibrillation: the Atherosclerosis Risk in Communities cohort.
about
Almanac 2015: atrial fibrillation research in HeartLink Between Non-Alcoholic Fatty Liver Disease and Atrial Fibrillation: A Systematic Review and Meta-Analysis.Nonalcoholic Fatty Liver Disease (NAFLD) and Risk of Cardiac Arrhythmias: A New Aspect of the Liver-heart Axis.Non-Alcoholic Fatty Liver Disease as a Predictor of Atrial Fibrillation in Middle-Aged Population (OPERA Study).Metabolomics and Incidence of Atrial Fibrillation in African Americans: The Atherosclerosis Risk in Communities (ARIC) StudyNonalcoholic fatty liver disease and increased risk of 1-year all-cause and cardiac hospital readmissions in elderly patients admitted for acute heart failure.γ-Glutamyltransferase and Risk of Sudden Cardiac Death in Middle-Aged Finnish Men: A New Prospective Cohort Study.Nonalcoholic Fatty Liver Disease Is Associated With Higher 1-year All-Cause Rehospitalization Rates in Patients Admitted for Acute Heart FailureAssociation of the Aspartate Aminotransferase to Alanine Aminotransferase Ratio with BNP Level and Cardiovascular Mortality in the General Population: The Yamagata Study 10-Year Follow-Up.Gamma-glutamyl transferase and cardiovascular disease.Cardiovascular Disease and Myocardial Abnormalities in Nonalcoholic Fatty Liver Disease.Baseline and long-term gamma-glutamyltransferase, heart failure and cardiac arrhythmias in middle-aged Finnish men: Prospective study and pooled analysis of published evidence.Gamma-glutamyltransferase-friend or foe within?Liver enzymes are not directly involved in atrial fibrillation: a prospective cohort study.Relations of Liver Fat With Prevalent and Incident Atrial Fibrillation in the Framingham Heart Study.Circulating ceruloplasmin, ceruloplasmin-associated genes, and the incidence of atrial fibrillation in the atherosclerosis risk in communities study.Linking atrial fibrillation with non-alcoholic fatty liver disease: potential common therapeutic targetsNAFLD/NASH in patients with type 2 diabetes and related treatment options.
P2860
Q26770598-D2774155-3B8C-4C20-918A-7557B7166172Q33643887-AD099D4C-336F-48DF-98E6-D0E3E8EA4445Q33805278-CE7EE343-301F-44E0-A4BC-1C916B342D29Q35841934-DE854001-1DE6-4D4A-806A-E34ABCFF4B4AQ36257878-75E9C020-3DB5-4027-AEB7-0DFEC6952C36Q36306272-1DDAAC71-9D65-4E24-8C26-39AA3CE6A364Q36714040-0790AEE1-3819-497E-AB76-5CF67EDC3B1EQ37206133-523B2F47-3F47-48A6-9B63-51421C3B8094Q37411680-FC2DD3F6-C53B-432F-B1C7-F060E25EC004Q37583757-9A2AA03C-691F-4651-A9B4-774589833DD1Q38711424-83B478A6-E292-4F57-A5FB-BC2109319EA3Q38880366-C7680F1E-31AA-47D5-AACC-A68992515611Q38924608-43CBEB74-6772-4D1C-8796-BE9EB4A70EC3Q40140195-84D77D75-7C8E-4EF2-A805-680436303817Q40218239-4F60772C-56F1-4861-97BB-ACB6356D5A9FQ40233926-5B2B2459-B669-409C-B79F-5930CFF714B2Q41694135-A9BA68EF-595A-4B0C-81AD-ACD4C7B8127FQ47592767-753EFC8F-7803-4BC3-83D4-4AD983CFADA4
P2860
Circulating levels of liver enzymes and incidence of atrial fibrillation: the Atherosclerosis Risk in Communities cohort.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Circulating levels of liver en ...... is Risk in Communities cohort.
@ast
Circulating levels of liver en ...... is Risk in Communities cohort.
@en
Circulating levels of liver en ...... is Risk in Communities cohort.
@nl
type
label
Circulating levels of liver en ...... is Risk in Communities cohort.
@ast
Circulating levels of liver en ...... is Risk in Communities cohort.
@en
Circulating levels of liver en ...... is Risk in Communities cohort.
@nl
prefLabel
Circulating levels of liver en ...... is Risk in Communities cohort.
@ast
Circulating levels of liver en ...... is Risk in Communities cohort.
@en
Circulating levels of liver en ...... is Risk in Communities cohort.
@nl
P2093
P2860
P50
P1433
P1476
Circulating levels of liver en ...... is Risk in Communities cohort.
@en
P2093
Elsayed Z Soliman
Jeffrey R Misialek
Laura R Loehr
Lin Y Chen
Mohamed A Amiin
Sunil K Agarwal
P2860
P304
P356
10.1136/HEARTJNL-2014-305756
P407
P577
2014-06-12T00:00:00Z